|
|
|
|
Cytokinetics Incorporated (CYTK) |
|
|
|
| |
Cytokinetics Incorporated's Leverage Ratio
CYTK's quarterly Leverage Ratio and Total Liabilities, Equity growth
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| CYTK Leverage Ratio |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
(Mar 31 2023)
I. Quarter |
(Dec 31 2022)
IV. Quarter |
(Sep 30 2022)
III. Quarter |
| Y / Y Equity Change |
- |
- |
- |
- |
- |
| Y / Y Total Liabilities Change |
8.02 % |
69.86 % |
52.25 % |
90.5 % |
90.44 % |
| Leverage Ratio MRQ |
- |
- |
- |
- |
- |
| CYTK's Total
Ranking |
# |
# |
# |
# |
# |
| Seq. Equity Change |
- |
- |
- |
- |
- |
| Seq. Total Liabilities Change |
5.91 % |
-0.66 % |
-0.48 % |
3.16 % |
66.55 % |
| Leverage Ratio third quarter 2023 Company Ranking |
| Within: |
No. |
| Major Pharmaceutical Preparations Industry |
# |
| Healthcare Sector |
# |
| Overall Market |
# |
| Leverage Ratio Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 |
|
|
|
Cumulative Cytokinetics Incorporated's Leverage Ratio
CYTK's Leverage Ratio for the trailling 12 Months
CYTK Leverage Ratio |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
(Mar 31 2023)
I. Quarter |
(Dec 31 2022)
IV. Quarter |
(Sep 30 2022)
III. Quarter |
| Y / Y Equity TTM Growth |
- |
- |
- |
- |
- |
| Y / Y Total Liabilities TTM Growth |
8.02 % |
69.86 % |
52.25 % |
90.5 % |
90.44 % |
| Leverage Ratio TTM |
- |
- |
- |
34.27 |
6.65 |
| Total
Ranking TTM |
|
|
|
|
|
| Seq. Equity TTM Growth |
- |
- |
- |
- |
- |
| Seq. Total Liabilities TTM Growth |
5.91 % |
-0.66 % |
-0.48 % |
3.16 % |
66.55 % |
On the trailing twelve months basis During the 12 months period ending III Quarter 2023 company had stockholder deficit. Leverage Ratio is the average cumulative value over the last four quarters.
Among companies in the Major Pharmaceutical Preparations industry CYTK recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.
Explain Leverage Ratio?
Who are CYTK Customers?
What are CYTK´s Total Liabilities?
| TTM Leverage Ratio Company Ranking |
| Within: |
No. |
| Within the Major Pharmaceutical Preparations Industry |
# |
| Healthcare Sector |
# |
| Within the Market |
# |
| trailing twelve months Leverage Ratio Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 | |
|
|
| Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry | Leverage Ratio | Sep 30 2023 MRQ Total Liabilities | Sep 30 2023 MRQ Equity |
|
Date modified: 2023-11-06T19:11:58+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
